Quick Answer
PRECISION BIOSCIENCES INC reported Revenue From Contract With Customer Excluding Assessed Tax of $34.26 million for the year ending 2025.
- PRECISION BIOSCIENCES INC showed a decrease of -50.1% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from PRECISION BIOSCIENCES INC's annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), PRECISION BIOSCIENCES INC's Revenue From Contract With Customer Excluding Assessed Tax has grown by 214.8%.
- Historical annual values: Fiscal year 2025: $34.26 million | Fiscal year 2024: $68.70 million | Fiscal year 2023: $48.73 million | Fiscal year 2022: $25.10 million | Fiscal year 2021: $115.53 million | Fiscal year 2020: $24.29 million | Fiscal year 2019: $22.24 million | Fiscal year 2018: $10.88 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: